BioSapien
Biosapien is a late-stage pre clinical company focused on novel drug delivery platforms. MediChip™ offers a revolutionary approach to localized cancer treatment. Imagine a tiny, bio-compatible patch – like a band-aid for the inside of your body – that delivers medication directly to the tumor site.
Total Fundraised$49.6M
2018
Abu Dhabi, United Arab Emirates
1 - 10
Pre-Series A
https://biosapien.com/BioSapien's Stages
Seed
Debt Financing
Grant
Pre-Series A
Funding Types by Funds Raised (in USD)
Content Locked
Login or Register a FREE account to continue browsing our content
Cumulative Funding Raised Over Time
Content Locked
Login or Register a FREE account to continue browsing our content
BioSapien's Investors by Funding Rounds
| Funding Round | Announced Date | Disclosed Investors | Round Amount (USD) |
|---|---|---|---|
Seed | 12 Sep 2019 | RebelBio SOSV | - 2 Investors |
Debt Financing | 20 Jan 2020 | RebelBio SOSV | - 2 Investors |
Seed | 11 Nov 2021 | JPIN Venture Catalysts Kartik Garg MicroVentures Side Door Ventures SOSV Cedas Foundation George and Saul Harbr Hikma Ventures Infinity Capital Beni VC | 1.8M 11 Investors |
Content Locked
Login or Register a FREE account to continue browsing our content
%2Fuploads%2Fpr%2520articles%2F2025%2F01%2F27_2biosapien.jpg&w=3840&q=75)
%2Fuploads%2Fpr%2520articles%2F2024%2F12%2F12_6biosapien.jpg&w=3840&q=75)
